This report contains market size and forecasts of Inhaled Nitric Oxide Delivery Device in global, including the following market information:
Global Inhaled Nitric Oxide Delivery Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Inhaled Nitric Oxide Delivery Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Inhaled Nitric Oxide Delivery Device companies in 2021 (%)
The global Inhaled Nitric Oxide Delivery Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inhaled Nitric Oxide Delivery Device for Children Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inhaled Nitric Oxide Delivery Device include Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED and Bellerophon Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inhaled Nitric Oxide Delivery Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhaled Nitric Oxide Delivery Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inhaled Nitric Oxide Delivery Device Market Segment Percentages, by Type, 2021 (%)
Inhaled Nitric Oxide Delivery Device for Children
Inhaled Nitric Oxide Delivery Device for Adults
Global Inhaled Nitric Oxide Delivery Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inhaled Nitric Oxide Delivery Device Market Segment Percentages, by Application, 2021 (%)
Hypoxic Respiratory Failure (HRF)
Acute Hypoxemic Respiratory Failure (AHRF)
Chronic Obstructive Pulmonary Disease (COPD)
Others
Global Inhaled Nitric Oxide Delivery Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inhaled Nitric Oxide Delivery Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inhaled Nitric Oxide Delivery Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Inhaled Nitric Oxide Delivery Device revenues share in global market, 2021 (%)
Key companies Inhaled Nitric Oxide Delivery Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Inhaled Nitric Oxide Delivery Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mallinckrodt Pharmaceuticals
Getinge
Vero Biotech
LINDE
Beyond Air
Air Liquide Healthcare
Circassia Pharmaceuticals
NU MED
Bellerophon Therapeutics
Praxair Technology Inc.